Regeneron Pharmaceuticals (NQ: REGN )
1,199.12
+11.46
(+0.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Headline News about Regeneron Pharmaceuticals
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/dna__image_by_arek_socha_from_pixabay_1.jpg)
![](https://g.foolcdn.com/editorial/images/631980/scientist-presenting-to-investors-getty.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_863.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/lab.louis-reed-pwckf7l4-no-unsplash_0.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/ms_park_destinationcharging_7.jpg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_840.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/stock-market-4440015_1920_15.jpg?width=720)
![](https://g.foolcdn.com/editorial/images/632029/biotech-scientist-microscope-getty.jpg)
![](https://g.foolcdn.com/editorial/images/632014/dna-helixes-with-doctor-in-background.jpg)
![](https://www.investors.com/wp-content/uploads/2021/06/Stock-crispr-01-adobe.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/intellia-therapeutics-headquarters-in-cambridge-mass.-scaled-1.jpg?width=720)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_a_1600.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_818.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_803.png)
![](https://g.foolcdn.com/editorial/images/631206/two-people-shaking-hands.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_780.png)
![](https://g.foolcdn.com/editorial/images/631081/time-to-buy-stopwatch.jpg)
![](https://g.foolcdn.com/editorial/images/631028/lady-looking-in-mirror-touching-her-cheek.jpg)
![](https://images.pexels.com/photos/4033021/pexels-photo-4033021.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_744.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pills-_image_by_thomas_breher_from_pixabay.jpg)
Biden Administration Devotes Over $3.2B For Development Of Oral Antiviral Therapies For COVID-19: CNBC
June 17, 2021
Via Benzinga
Exposures
COVID-19
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://www.investors.com/wp-content/uploads/2021/06/Stock-Elanco-shutt.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_344.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cdc-cfs6a4u5g8m-unsplash_0.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_684.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.